BIOMARIN PHARMACEUTICAL INC — DEF 14A Filings
24 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by BIOMARIN PHARMACEUTICAL INC (BMRN), sorted by most recent first. Each row links to the full filing on EdgarLookup. BIOMARIN PHARMACEUTICAL INC has filed 24 DEF 14A documents with the SEC since 2016. To view all SEC filings by BIOMARIN PHARMACEUTICAL INC, see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
305B2
4
4/A
424B1
424B2
424B3
424B4
424B5
5
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFC14A
DEFM14A
DEFR14A
DFAN14A
EFFECT
FWP
NO ACT
POS AM
PRE 14A
PREC14A
PREM14A
PRER14A
PRRN14A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001048477-25-000045 | Apr 8, 2025 | May 20, 2025 |
| DEF 14A | DEF 14A | 0001048477-24-000058 | Apr 9, 2024 | May 21, 2024 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001308179-23-000635 | Apr 11, 2023 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001206774-22-001085 | Apr 12, 2022 | May 24, 2022 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001206774-21-001100 | Apr 13, 2021 | May 25, 2021 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001206774-20-001169 | Apr 14, 2020 | May 27, 2020 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001206774-19-001403 | Apr 23, 2019 | Jun 4, 2019 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001206774-18-001344 | Apr 24, 2018 | Jun 5, 2018 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001206774-17-001396 | Apr 25, 2017 | Jun 6, 2017 |
| DEF 14A | DEF 14A | 0001564590-16-016546 | Apr 25, 2016 | Jun 6, 2016 |
| DEF 14A | DEF 14A | 0001193125-15-143877 | Apr 23, 2015 | Jun 9, 2015 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001193125-14-151302 | Apr 22, 2014 | Jun 4, 2014 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001193125-13-143464 | Apr 5, 2013 | May 15, 2013 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001193125-12-129343 | Mar 23, 2012 | May 8, 2012 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001193125-11-080924 | Mar 29, 2011 | May 12, 2011 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001193125-10-068674 | Mar 26, 2010 | May 12, 2010 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001193125-09-071707 | Apr 2, 2009 | May 12, 2009 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001193125-08-078042 | Apr 9, 2008 | May 22, 2008 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001193125-07-095904 | Apr 30, 2007 | Jun 7, 2007 |
| DEF 14A | NOTICE & PROXY STATEMENT | 0001193125-06-113691 | May 16, 2006 | Jun 21, 2006 |
| DEF 14A | NOTICE AND PROXY STATEMENT | 0001193125-04-055533 | Apr 1, 2004 | May 5, 2004 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001193125-03-002493 | Apr 30, 2003 | Jun 12, 2003 |
| DEF 14A | SCHEDULE 14.A | 0001048477-02-000057 | Jul 31, 2002 | Jul 30, 2002 |
| DEF 14A | BIOMARIN PHARMACEUTICAL INC. PROXY | 0001048477-00-000009 | Apr 28, 2000 | Dec 31, 1999 |